Abstract
Incorporation of a naphthalene-dialdehyde moiety into the δ antagonist, 6′-aminonaltrindole afforded a potent, selective, irreversible δ-agonist 1. However, flow cytometry studies revealed no time-dependent specific fluorescence, suggesting that both Lys214 and Cys216 at the recognition site are not involved in covalent binding. Molecular simulation studies suggest that compound 1 may form a Schiff base with the ε-amino group of Lys214, which could explain its irreversibility and transformation into a δ-agonist through a conformational change of TM5.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3392-3396 |
| Number of pages | 5 |
| Journal | Journal of medicinal chemistry |
| Volume | 50 |
| Issue number | 14 |
| DOIs | |
| State | Published - Jul 12 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'o-naphthalenedicarboxaldehyde derivative of 7′-aminonaltrindole as a selective δ-opioid receptor affinity label'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS